Loading institutional data...
Loading institutional data...
Held by 247 of 5,944 reporting institutions (93th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $33.63 today, the market must believe free cash flow compounds 20.2%/yr for a decade (off $25M normalized FCF).
The market's 20.2% is more optimistic than its 9-yr track record.
2-stage DCF · 0.05B shares · net debt -$280M
mean -58.8% · volatility σ 319% · implied rate exceeded in 2/6 yrs
Central path = implied 20.2%/yr growth; shaded band = ±1σ (319%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $593.8M 100.0% | $573.4M 100.0% | $551.5M 100.0% | $555.5M 100.0% | $513.7M 100.0% | $388.5M 100.0% | $334.2M 100.0% | $631.6M 100.0% | $527.5M 100.0% | $434.0M 100.0% |
| Cost of Revenue | $323.5M 54.5% | $318.8M 55.6% | $312.3M 56.6% | $299.9M 54.0% | $269.9M 52.5% | $216.4M 55.7% | $199.6M 59.7% | $385.5M 61.0% | $425.5M 80.7% | $362.2M 83.5% |
| Cost of Products | — | — | — | — | — | — | — | $288.3M 45.7% | $249.4M 47.3% | $212.0M 48.9% |
| Cost of Services | — | — | — | — | — | — | — | $97.2M 15.4% | $79.2M 15.0% | $65.3M 15.0% |
| Gross Profit | $270.3M 45.5% | $254.6M 44.4% | $239.2M 43.4% | $255.6M 46.0% | $243.8M 47.5% | $172.1M 44.3% | $134.6M 40.3% | $246.1M 39.0% | $198.9M 37.7% | $156.7M 36.1% |
| Research & Development | $30.4M 5.1% | $31.5M 5.5% | $32.1M 5.8% | $27.5M 5.0% | $22.4M 4.4% | $17.8M 4.6% | $17.3M 5.2% | $46.9M 7.4% | $39.9M 7.6% | $44.2M 10.2% |
| Selling, General & Admin | $261.6M 44.0% | $263.0M 45.9% | $263.7M 47.8% | $251.5M 45.3% | $252.1M 49.1% | $190.3M 49.0% | $163.3M 48.9% | $167.0M 26.4% | $141.5M 26.8% | $119.3M 27.5% |
| Total Operating Expenses | $297.1M 50.0% | $305.9M 53.3% | $300.5M 54.5% | $280.3M 50.5% | $274.9M 53.5% | $208.7M 53.7% | $182.0M 54.5% | $214.7M 34.0% | $184.6M 35.0% | $173.7M 40.0% |
| Operating Income | -$26.8M -4.5% | -$51.3M -8.9% | -$61.2M -11.1% | -$24.7M -4.5% | -$31.1M -6.1% | -$36.6M -9.4% | -$47.4M -14.2% | $31.4M 5.0% | $14.3M 2.7% | -$17.1M -3.9% |
| Interest Expense | — | — | — | $4.6M 0.8% | $2.0M 0.4% | $2.9M 0.8% | $22.3M 6.7% | $9.5M 1.5% | $408K 0.1% | $157K 0.0% |
| Interest & Investment Income | — | $33.2M 5.8% | $43.7M 7.9% | $15.7M 2.8% | — | — | — | — | — | $452K 0.1% |
| Other Income (Expense), net | $922K 0.2% | -$732K -0.1% | -$2.3M -0.4% | -$898K -0.2% | -$16.5M -3.2% | -$1.6M -0.4% | -$1.4M -0.4% | -$3.3M -0.5% | -$1.7M -0.3% | -$1.4M -0.3% |
| Pretax Income | -$7.1M -1.2% | -$19.1M -3.3% | -$20.0M -3.6% | -$9.9M -1.8% | -$49.0M -9.5% | -$40.3M -10.4% | -$84.0M -25.1% | $20.5M 3.2% | $14.5M 2.8% | -$18.1M -4.2% |
| Income Tax Expense | -$31.6M -5.3% | $5.2M 0.9% | -$12.0M -2.2% | $1.4M 0.2% | -$20.1M -3.9% | -$13.9M -3.6% | -$22.8M -6.8% | -$47.3M -7.5% | $3.4M 0.6% | $66.3M 15.3% |
| Net Income | -$55.8M -9.4% | -$164.9M -28.8% | -$14.6M -2.7% | $2.13B 384.0% | $110.7M 21.6% | $64.9M 16.7% | $437.4M 130.9% | $116.6M 18.5% | $62.6M 11.9% | -$69.5M -16.0% |
| Per Share | ||||||||||
| EPS (Basic) | $-1.22 | $-3.10 | $-0.22 | $28.48 | $1.49 | $0.88 | $6.08 | $1.65 | $0.90 | $-1.01 |
| EPS (Diluted) | $-1.22 | $-3.10 | $-0.22 | $28.48 | $1.49 | $0.88 | $6.04 | $1.64 | $0.89 | $-1.01 |
| Weighted Avg Shares (Basic) | 45.7M | 53.2M | 66.3M | 74.9M | 74.2M | 73.6M | 72.0M | 70.5M | 69.6M | 68.5M |
| Weighted Avg Shares (Diluted) | 45.9M | 53.2M | 66.3M | 74.9M | 74.5M | 73.8M | 72.4M | 70.9M | 70.5M | 68.5M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
5/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $38M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A balanced mix of reinvestment and shareholder returns.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -3%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $280M covers the $0 due within a year 279783000.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2019-06-30 (10-Q).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Interest last disclosed in FY2022 (no longer broken out).
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $340.0B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $244.5B | 36.5× | 31.5× | 5.5× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $130.4B | 33.5× | 28.6× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| AZTA | $1.5B | — | 244.8× | 2.6× | 3.6% | 45.5% | -9.4% | -3.2% | -3.2% | — | 247 |
Peers = companies sharing AZTA's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-09-17
No standout strengths flagged.
Where each multiple sits in its own 14-yr range · 55th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 61.0 | 59.7 | 55.7 | 52.5 | 54.0 | 56.6 | 55.6 | 54.5 |
| Gross Profit | 39.0 | 40.3 | 44.3 | 47.5 | 46.0 | 43.4 | 44.4 | 45.5 |
| R&D | 7.4 | 5.2 | 4.6 | 4.4 | 5.0 | 5.8 | 5.5 | 5.1 |
| SG&A | 26.4 | 48.9 | 49.0 | 49.1 | 45.3 | 47.8 | 45.9 | 44.0 |
| Operating Income | 5.0 | -14.2 | -9.4 | -6.1 | -4.5 | -11.1 | -8.9 | -4.5 |
| Income Tax | -7.5 | -6.8 | -3.6 | -3.9 | 0.2 | -2.2 | 0.9 | -5.3 |
| Net Income | 18.5 | 130.9 | 16.7 | 21.6 | 384.0 | -2.7 | -28.8 | -9.4 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on AZTA: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.